Hinge Health (NYSE:HNGE) Reaches New 1-Year High After Earnings Beat

Hinge Health Inc. (NYSE:HNGE) reached a new 52-week high during trading on Monday following a stronger than expected earnings report. The company traded as high as $118.74 and last traded at $117.8360, with a volume of 410,996 shares. The stock had previously closed at $114.32.

The company reported $0.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.44. The company had revenue of $234.97 million for the quarter. Hinge Health had a return on equity of 73.91% and a net margin of 21.02%. The firm’s revenue for the quarter was up 52.4% compared to the same quarter last year. During the same period last year, the company earned ($0.02) EPS.

More Hinge Health News

Here are the key news stories impacting Hinge Health this week:

• Positive Sentiment: Strong Q3 results: Revenue rose 52.4% year over year to about $235 million, beating estimates, while earnings of $0.71 per share also exceeded consensus. Hinge Health reports record third quarter 2026 financial results
• Positive Sentiment: Raised outlook: Hinge Health forecast 2026 revenue of $879 million–$881 million, above the roughly $858.5 million consensus. Its Q4 revenue outlook of $249 million–$251 million also topped estimates, reinforcing expectations for continued growth. Hinge Health outlines 2026 revenue outlook
• Positive Sentiment: More bullish analyst targets: Morgan Stanley, Truist, RBC, Canaccord and Stifel raised their price targets, maintaining positive ratings. Truist’s new $145 target was the highest among those cited. Truist analyst recommendations
• Positive Sentiment: Expansion potential: The company is broadening beyond musculoskeletal care, including plans for an integrated gastrointestinal program, and is evaluating hardware acquisitions—potential avenues for future growth. Hinge Health expands care offerings
• Negative Sentiment: Valuation and expectations: HNGE has gained 156% year to date and is near its 52-week high. That run-up may leave shares vulnerable if growth or results fall short of heightened investor expectations. Hinge Health stock looks stretched after its year-to-date run

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the company. Stifel Nicolaus raised their price target on Hinge Health from $130.00 to $135.00 and gave the company a “buy” rating in a research note on Tuesday. Robert W. Baird lifted their price objective on Hinge Health from $85.00 to $90.00 and gave the company a “neutral” rating in a report on Tuesday, September 22nd. Weiss Ratings lowered shares of Hinge Health from a “hold (c)” rating to a “hold (c-)” rating in a research note on Thursday, October 8th. Truist Financial increased their target price on shares of Hinge Health from $112.00 to $145.00 and gave the stock a “buy” rating in a report on Tuesday. Finally, Morgan Stanley raised their target price on shares of Hinge Health from $117.00 to $131.00 and gave the company an “overweight” rating in a research report on Tuesday. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $118.93.

Insider Buying and Selling

In other news, President James Pursley sold 33,000 shares of Hinge Health stock in a transaction on Monday, September 21st. The stock was sold at an average price of $94.14, for a total value of $3,106,620.00. Following the transaction, the president directly owned 666,909 shares in the company, valued at approximately $62,782,813.26. This trade represents a 4.71% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Daniel Perez sold 4,100 shares of the business’s stock in a transaction on Tuesday, October 6th. The stock was sold at an average price of $100.20, for a total value of $410,820.00. Following the completion of the transaction, the chief executive officer directly owned 4,100 shares of the company’s stock, valued at approximately $410,820. The trade was a 50.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,024,581 shares of company stock worth $95,632,761 in the last three months. Corporate insiders own 18.92% of the company’s stock.

Institutional Investors Weigh In On Hinge Health

A number of institutional investors have recently added to or reduced their stakes in HNGE. IFP Advisors Inc boosted its position in shares of Hinge Health by 140.0% in the 2nd quarter. IFP Advisors Inc now owns 324 shares of the company’s stock worth $27,000 after purchasing an additional 189 shares in the last quarter. Nykredit A S purchased a new position in Hinge Health during the 2nd quarter worth $29,000. SBI Securities Co. Ltd. grew its stake in Hinge Health by 39.5% during the 3rd quarter. SBI Securities Co. Ltd. now owns 364 shares of the company’s stock worth $35,000 after buying an additional 103 shares during the last quarter. Sterling Capital Management LLC increased its position in Hinge Health by 899.3% during the 3rd quarter. Sterling Capital Management LLC now owns 1,469 shares of the company’s stock valued at $143,000 after buying an additional 1,322 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC acquired a new position in Hinge Health during the 3rd quarter valued at about $204,000.

Hinge Health Stock Up 3.4%

The business has a 50 day simple moving average of $99.21 and a 200 day simple moving average of $67.72. The company has a market capitalization of $9.75 billion, a PE ratio of 61.62 and a beta of 1.19.

Hinge Health Company Profile

Hinge Health is a digital healthcare company focused on musculoskeletal (MSK) conditions, including back and joint pain. The company provides virtual care programs designed to help members manage pain, improve mobility and reduce the need for more costly or invasive treatments.

Its platform combines personalized exercise therapy, behavioral support, education and access to clinical professionals. Hinge Health also uses technologies such as motion-sensing wearable devices and artificial intelligence to help guide exercises, monitor progress and tailor care plans to individual needs.

Hinge Health primarily serves employers and health plans, which offer its programs to eligible members in the United States.